Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Attended This Year’s H.C. Wainwright Bioconnect Virtual Conference
Delic Holdings Corp is a leader in new medicines and treatments for a modern world, with a business network which…
Delic Holdings Corp is a leader in new medicines and treatments for a modern world, with a business network which…
Mr. Josh Bartch, the CEO, Chairman, and Co-Founder of Mydecine, attributed the company’s success to its phased approach to product…
Mineral property exploration company StraightUp Resources enters 2022 with a new CEO, the tailwind from a new OTCQB Market listing,…
Company marked host of major milestones and accomplishments in 2021 Approvals, licenses, expansions and growth all essential pieces of Cybin…
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has commented on a recent study that indicated that cannabinoids…
Growth Capital Acquisition Corp. (NASDAQ: GCAC) and its wholly owned subsidiary, GCAC Merger Sub Inc., previously entered into a business…
FingerMotion (NASDAQ: FNGR), a mobile data and services company, is reporting financial results for the third quarter, the period ended…
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service…
Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has…
Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology and digital technology company aiming to transform the treatment of mental…